IRCT20200127046282N18
Recruiting
Phase 1
Evaluation the efficacy of mesenchymal stem cells condition medium on hair transplantation outcome
Skin and Stem cell Research Center of Tehran University of Medical Sciences0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Hair loss.
- Sponsor
- Skin and Stem cell Research Center of Tehran University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Candidate hair transplant patients
- •Absence of internal diseases except hypothyroidism
- •Do not take drugs that cause hair loss such as chemotherapy, psychotropic drugs, anticoagulants, cardiovascular, retinoids, antimicrobials, androgen hormones
- •Absence of psychiatric diseases such as obsessive\-compulsive disorder and trichotillomania
- •Absence of active infection in the transplanted area
- •Age between 18\-50 years
Exclusion Criteria
- •Reluctance to continue cooperation
- •Breastfeeding
- •Exposure to acute and severe stress during the study
- •Allergy to xylocaine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeModerate to severe SARS-Cov-2 related acute respiratory distress syndromeMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2020-002772-12-FRCHRU NANCY30
Completed
Phase 1
Evaluation of Mesenchymal stem cell therapy effects on the cellular immune response in refractory rheumatoid arthritis patientsRheumatoid arthritis.Diseases of the musculoskeletal system and connective tissueIRCT2015102824760N1Research Chancellor, Mashhad University of Medical Sciences21
Completed
Not Applicable
To investigate the efficacy of mesenchymal stem cell conditioned media (MSCs-CM) on ameliorate maturation and developmental potential of immature human oocytes after artificial activation in the infertile female.IRCT2017101736840N1Vice Chancellor for Research, Kerman University of Medical Sciences100
Completed
Not Applicable
Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantatiorefractoty acute GVHD after stem cell transplantationJPRN-C000000423Jichi Medical University, Department of Medicine, Division of Hematology5
Completed
Not Applicable
Effects of mesenchymal stem cells therapy in peritoneal dialysis patientsChronic kidney disease.Chronic kidney disease, stage 5IRCT2015052415841N2Vice chancellor for research, Tehran University of Medical Sciences10